Genital Herpes
📧 Sign up to get email alerts when something new happens for Genital Herpes.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2010-05-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original application for valacyclovir hydrochloride (valacyclovir) by Mylan Pharmaceuticals Inc., a generic antiviral. The …
-
FDA approval · 2010-05-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Original Application (TIME CAP LABORATORIES, INC.)
FDA approved Valacyclovir hydrochloride from Time Cap Laboratories under an Original Abbreviated New Drug Application.
-
FDA approval · 2010-05-24FDA Approved: VALACYCLOVIR HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
FDA approves a generic valacyclovir hydrochloride product from Aurobindo Pharma Limited under an Original Application (ANDA). It is indicate…
-
FDA approval · 2010-04-19FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) submitted by GlaxoSmithKline LLC.
-
FDA approval · 2009-04-29FDA Approved: FAMCICLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a Teva Pharmaceuticals supplemental application for famciclovir, resulting in an updated indication/label for the generic a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2009-01-09Clinical Trial Update: HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult Population
A completed study protocol for evaluating the HerpeSelect Express Rapid Test for HSV-2 in sexually active adults.
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212) [Phase 2]
This document reports an update on a Phase 2 trial evaluating anti-herpetic treatment for genital ulcers (ANRS 1212) and its effect on HIV a…
-
CLINICAL_TRIALS trial_result · 2008-10-27Clinical Trial Update: Trial Evaluating Safety, Tolerability and Immune Response of AG-707 [Phase 1]
This Phase 1 trial evaluated the safety, tolerability, and immune response of AG-707 for genital herpes and has completed.
-
FDA approval · 2007-12-11FDA Approved: VALTREX — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Valtrex (valacyclovir hydrochloride) submitted by GlaxoSmithKline LLC, authorizing changes t…
-
FDA approval · 2007-08-24FDA Approved: FAMCICLOVIR — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic famciclovir (Original Application). This approval expands access to an antiviral for the treatment of herpes zos…
-
CLINICAL_TRIALS trial_result · 2007-08-10Clinical Trial Update: Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community [Phase 3]
A Phase 3 clinical trial update on the effects of male circumcision on HIV, sexually transmitted infections, and related behaviors in men, w…
-
FDA approval · 2007-01-31FDA Approved: VALACYCLOVIR — Original Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
FDA approved Sun Pharmaceutical Industries' original-application generic valacyclovir (valacyclovir), authorizing its marketing as an antivi…
-
CLINICAL_TRIALS trial_result · 2007-01-29Clinical Trial Update: Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2 [Phase 1]
Completion of a Phase 1 safety study evaluating an HSV-2 DNA vaccine for recurrent genital herpes caused by HSV-2.
-
CLINICAL_TRIALS trial_result · 2006-06-07Clinical Trial Update: Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV Shedding [Phase 2]
A Phase 2 randomized trial evaluated whether suppressive therapy for genital herpes affects HIV shedding.